Why AML Marketing Doesn't Sound Like Marketing (And Shouldn't)

5 MINS

Most product marketing playbooks were written for a buyer who is allowed to be excited. AML and fraud buyers are not that buyer. They sit inside a regulator-facing function where being wrong is more expensive than being late, and where a single line of misleading copy can become an evidentiary problem six months later.

After a few years inside Tookitaki and now Mozn, I've come to believe that good AML marketing barely sounds like marketing at all.

The buyer is reading defensively

A compliance officer evaluating an AML platform is not asking "is this exciting?" They are asking "if my regulator audits me on this decision next year, can I defend it?"

That changes everything about what we put on a website:

Outcomes that don't survive a regulator's inspection are worse than no outcome at all.

"AI-powered" without explanation is a red flag, not a benefit.

Case studies need methodology, not glossy quotes. The instinct to soften, polish, and abstract — the instinct most marketing teams are trained to act on — is exactly what undermines trust here.

Three rules I've ended up writing on every brief

1. Lead with the typology, not the technology. A bank doesn't buy "graph neural networks." They buy "we caught a mule network we couldn't see before, and here is the typology it expressed." Start there. The model is a footnote.

2. Numbers in the specific, not the absolute. "70% reduction in false positives" is a marketing claim. "70% reduction across this dataset, this segment, this typology, this period" is a defensible claim. The first one ages badly. The second one earns the next meeting.

3. Treat the analyst as part of the GTM motion. In RegTech, analysts (Chartis, Datos, Celent) carry a disproportionate amount of buyer trust. If your narrative isn't tight enough to survive a 30-minute analyst briefing, it isn't tight enough to put on the homepage either.

The quiet competitive advantage

Here's the thing nobody outside this space appreciates: in AML and fraud, the market rewards the team that is *least* hyperbolic. Compliance officers talk to each other. Reputation in this space is built slowly and broken in a single quarterly earnings call where someone overpromises a model.

So the actual competitive moat isn't louder messaging. It is messaging that survives scrutiny — from procurement, from legal, from the second-line risk team, and eventually from the regulator who reads the trail of marketing claims you made when something goes wrong.

That is a different craft from B2B SaaS marketing for, say, a developer tool. It is closer to legal writing with empathy.

What I tell my team

When in doubt, write less. Cite more. Show the methodology. Assume the smartest person at the customer is reading at midnight, half-tired, and looking for a reason to disqualify you. Earn the next meeting, not the click.

That is how AML marketing earns trust — and trust, in this category, is the only growth lever that compounds.

I've Sat in Four Chairs Around the GTM Table. They All Disagree.

Anup skipped presentations and built real AI products.

Anup Gunjan was part of the March 2026 cohort at Curious PM, alongside 17 other talented participants.